Curemark is a private, clinical-stage biopharmaceutical company developing novel therapies for the treatment of serious unmet needs in neuro-developmental and neurodegenerative disorders. The company's pipeline includes preclinical and clinical-stage programs for the treatment of autism, schizophrenia, Parkinson's disease, ADHD and addiction.

https://curemark.com/

Biopharma

Therapeutics

Pharmaceutical

Health Care

Biotechnology

Village Of Rye Brook, New York, United States

Curemark announced it raised $1.3 Million in an initial filing from an offering of $15 Million

Company Information

Related People

Curemark announced it raised $1.3 Million in an initial filing from an offering of $15 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information